Form 4: Protagonist Therapeutics CEO Transfers Shares as Gift
SEC Form 4 Filing
Protagonist Therapeutics CEO, Dinesh V. Patel, gifted 1,000 shares of common stock to his grandchild.
Summary
- Dinesh V. Patel, the President and CEO of Protagonist Therapeutics, gifted 1,000 shares of common stock.
- The transaction occurred on November 19, 2024.
- The shares were gifted directly and not sold, with a price of $0.
- Following the transaction, Mr. Patel beneficially owns 513,415 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a neutral transaction report, not indicative of positive or negative sentiment.
Industry Context
This is a routine filing related to changes in beneficial ownership by a company insider and is not indicative of any broader industry trends.
Comparison to Industry Standards
- Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders across all publicly traded companies.
- The gifting of shares is a personal transaction and does not reflect the company's performance or outlook.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a personal gift by the CEO and does not affect the company's operations or financial position.
Key Dates
| Date | Description |
|---|---|
| 11/19/2024 | Date of the stock gift transaction. |
| 11/21/2024 | Date the form was signed. |
Keywords
Protagonist Therapeutics, Dinesh V. Patel, stock gift, share transfer, beneficial ownership, CEO, equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.